Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder.

Information

  • Research Project
  • 10456354
  • ApplicationId
    10456354
  • Core Project Number
    UH3DA047925
  • Full Project Number
    4UH3DA047925-03
  • Serial Number
    047925
  • FOA Number
    RFA-DA-19-002
  • Sub Project Id
  • Project Start Date
    2/1/2019 - 5 years ago
  • Project End Date
    8/31/2023 - a year ago
  • Program Officer Name
    KLINE, RICHARD
  • Budget Start Date
    9/1/2021 - 3 years ago
  • Budget End Date
    8/31/2023 - a year ago
  • Fiscal Year
    2021
  • Support Year
    03
  • Suffix
  • Award Notice Date
    8/27/2021 - 3 years ago
Organizations

Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder.

IC Name
NATIONAL INSTITUTE ON DRUG ABUSE
  • Activity
    UH3
  • Administering IC
    DA
  • Application Type
    4
  • Direct Cost Amount
    2951596
  • Indirect Cost Amount
    501771
  • Total Cost
    3453367
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    279
  • Ed Inst. Type
  • Funding ICs
    NIDA:3453367\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZDA1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    BIOCORRX, INC.
  • Organization Department
  • Organization DUNS
    079276398
  • Organization City
    ANAHEIM
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    92806
  • Organization District
    UNITED STATES